Leishmania donovani Develops Resistance to Drug Combinations

Leishmaniasis Worldwide and Global Estimates of Its Incidence

(2012) Jorge Alvar et al.   PLoS One

Experimental Induction of Paromomycin Resistance in Antimony-Resistant Strains of L. donovani: Outcome Dependent on In Vitro Selection Protocol

(2012) Sarah Hendrickx et al.   PLoS Neglected Tropical Diseases

Molecular Mechanisms of Drug Resistance in Natural Leishmania Populations Vary with Genetic Background

(2012) Saskia Decuypere et al.   PLoS Neglected Tropical Diseases

Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis

(2012) Vasundhra Bhandari et al.   PLoS Neglected Tropical Diseases

Increased Glycolytic ATP Synthesis Is Associated with Tafenoquine Resistance inLeishmania major

(2011) José Ignacio Manzano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial

(2011) Shyam Sundar et al.   LANCET

Safety and Efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial

(2011) Raymond Omollo et al.   Trials

Tafenoquine, an Antiplasmodial 8-Aminoquinoline, Targets Leishmania Respiratory Complex III and Induces Apoptosis

(2010) L. Carvalho et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

New antileishmanial candidates and lead compounds

(2010) Julian V Richard et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

Drug combinations for visceral leishmaniasis

(2010) Piero L Olliaro   CURRENT OPINION IN INFECTIOUS DISEASES

In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent

(2010) K. Seifert et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Combination therapy for visceral leishmaniasis

(2010) Johan van Griensven et al.   LANCET INFECTIOUS DISEASES

Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent

(2010) Filip Meheus et al.   PLoS Neglected Tropical Diseases

In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences

(2009) M. Vermeersch et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Flow cytometric determination of intracellular non-protein thiols in Leishmania promastigotes using 5-chloromethyl fluorescein diacetate

(2009) Avijit Sarkar et al.   EXPERIMENTAL PARASITOLOGY

New Treatment Approach in Indian Visceral Leishmaniasis: Single‐Dose Liposomal Amphotericin B Followed by Short‐Course Oral Miltefosine

(2008) Shyam Sundar et al.   CLINICAL INFECTIOUS DISEASES